Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease

Heart and Vessels

Volumn 24, Issue 3, 2009, Pages 187-192

  Nishiyama, Mitsunori ^a   Park, In Sam ^a   Yoshikawa, Tadahiro ^a   Hatai, Yoshiho ^a   Ando, Makoto ^a   Takahashi, Yukihiro ^a   Mori, Katsuhiko ^a   Murakami, Yasuo ^a  

^a SAKAKIBARA HEART INSTITUTE   (Japan)

Author keywords

Beta blocker; Carvedilol; Children; Congenital heart disease; Heart failure

Indexed keywords

ATENOLOL; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; CATECHOLAMINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PHOSPHODIESTERASE III INHIBITOR; PIMOBENDAN;

ADOLESCENT; ADULT; ARTICLE; BRADYCARDIA; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; INFANT; ISCHEMIC HEART DISEASE; MALE; MYOCARDITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; WHEEZING;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; CARBAZOLES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROPANOLAMINES; TREATMENT OUTCOME;

EID: 66149097777     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1102-5     Document Type: Article

References (22)

1. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, US Carvedilol Heart Failure Study Group (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349-1355
2. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaign A, Roecker EB, Schultz MK, DeMets DL (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-1658
3. The CAPRICORN Investigators (2001) Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomized trial. Lancet 357:1385-1390
4. Cheung EWY, Lam WWM, Cheung SCW, Cheung Y (2008) Functional implications of the right ventricular myocardial performance index in patients after surgical repair of Tetralogy of Fallot. Heart Vessels 23:112-117
5. Man B, Cheung Y (2007) Plasma brain natriuretic peptide and systemic ventricular function in asymptomatic patients late after the Fontan procedure. Heart Vessels 22:398-403
6. Bruns LA, Chrisant MK, Lamour JM, Shaddy RE, Pahl E, Blume ED, Hallowell S, Addonizio LJ, Canter C (2001) Carvedilol as therapy in pediatric heart failure: An initial multicenter experience. J Pedatr 138:505-511
7. Laer S, Mir TS, Behn F, Eiselt M, Scholz H, Venzke A, Meibohm B, Weil J (2002) Carvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parameters. Am Heart J 143:916-922
8. Williams RV, Tani LY, Shaddy RE (2002) Intermediate effects of treatment with Metoprolol or Carvedilol in children with left ventricular systolic dysfunction. J Heart Lung Transplant 21:906-909
9. Giardini A, Formigari R, Bronzetti G, Prandstrller D, Donti A, Bonvicini M, Picchio FM (2003) Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol. Cardiol Young 13:333-336
10. Toyono M, Kondo C, Nakajima Y, Nakazawa M, Momma K, Kusakabe K (2001) Effects of Carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction. Heart 86:e4
11. Rusconi P, Gomez-Marin O, Rossique-Gonzalez M, Redha E, Marin JR, Lon-Young M, Wolff GS (2004) Carvedilol in children with Cardiomyopathy: 3-year experience at a single institution. J Heart Lung Transplant 23:832-838
12. Azeka E, Ramires JAF, Valler C, Bocchi EA (2002) Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol 40:2034-2038
13. Shaddy RE, Curtin EL, Sower B, Tani LY, Burr J, LaSalle B, Boucek MM, Mahony L, Hsu DT, Pahl E, Burch GH, Schlencker-Herceg R (2002) The pediatric randomized carvedilol trial in children with chronic heart failure: Rationale and design. Am Heart J 144:383-389
14. Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, Ross RD, Pahl E, Blume ED, Dodd DA, Rosenthal DN, Burr J, LaSalle B, Holubkov R, Lukas MA, Tani LY, For the Pediatric Carvedilol Study Group (2007) Carvedilol for Children and Adolescents With Heart Failure A Randomized Controlled Trial. JAMA 298(10):1171-1179
15. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I (1975) Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37:1022-1036
16. The Cardiac Arrhythmia Suppression Trial-II investigators (1992) The effect of the antiarrthymic agent moricizine on survival after myocardial infarction. N Engl J Med 327:227-233
17. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM (1989) Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT). Am J Cardiol 63:1518-1520
18. Kalinowski L, Dobrucki LW, Szczepanska-Konkel M, Jankowski M, Martyniec L, Angielski S, Malinski T (2003) Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: A novel mechanism for antihypertensive action. Circulation 107:2747-2752
19. Nakamura K, Kusano K, Nakamura Y, Kakishita M, Ohta K, Nagase S, Yamamoto M, Miyaji K, Saito H, Morita H, Emori T, Matsubara H, Toyokuni S, Ohe T (2002) Carvedilol decrease elevated oxidative stress in human failing myocardium. Circulation 105:2867-2871
20. Yue TL, Cheng HY, Lysko PG, Mckenna PJ, Feuersetein R, Gu JL, Lysko KA, Davis LL, Feuerstein G (1992) Carvedilol, a new vasodilator and beta adrenoreceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 263:92-98
21. The CONSESSUS trial study group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429-1435
22. Khattar RS, Senior R, Soman P, Does R, Lahiri A (2001) Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. Am Heart J 142:704-713